Sanara MedTech (SMTI) Change in Receivables (2010 - 2026)

Sanara MedTech has reported Change in Receivables for 16 years, with the latest figure at $1.7 million in Q1 2026.

• For the quarter ending Q1 2026, Change in Receivables rose 564.13% year-over-year to $1.7 million; the trailing twelve-month figure through Mar 2026 stood at $2.0 million (up 290.09% YoY), and the FY2025 full-year result was -$40566.0, down 226.11% from the prior year.
• Change in Receivables for Q1 2026 stood at $1.7 million, up from -$185525.0 in the prior quarter.
• The five-year high for Change in Receivables was $2.3 million in Q4 2022, with the low at -$2.1 million in Q3 2024.
• Historically, Change in Receivables has averaged $227118.1 across 5 years, with a median of $243198.0 in 2025.
• Annual changes were most pronounced in 2023 — Change in Receivables surged 715.47% — and 2025, when it plunged 6425.68%.
• Sanara MedTech's Change in Receivables stood at $2.3 million in 2022, then plunged by 139.12% to -$884492.0 in 2023, then jumped by 99.68% to -$2843.0 in 2024, then sank by 6425.68% to -$185525.0 in 2025, then jumped by 1021.35% to $1.7 million in 2026.
• The last three Change in Receivables figures came in at $1.7 million (Q1 2026), -$185525.0 (Q4 2025), and $270045.0 (Q3 2025), per Business Quant data.